[Short-term use of beclomethasone dipropionate in the treatment of spasmodic obstructive bronchopneumopathies].
Forty-two patients were treated with beclomethasone dipropionate in doses of 400 microgram daily for no longer than three months. There were three main indications : attempt to withdraw corticosteroids or sympathomimetics ; treatment prior to desensitization ; treatment of asthma with severe permanent dyspnea. In 8 patients, systemic steroids of sympathomimetic drugs could be withdrawn. Dosage could be reduced by 50% or more in 21 cases, and by less than 50% in 9 cases. There were 3 failures, and results were unassessable in one case. No major side-effects were observed.
D000281:Administration, Intranasal; D000336:Aerosols; D001249:Asthma / Q000188:drug therapy; D001507:Beclomethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D001982:Bronchial Diseases / Q000188:drug therapy*; D001986:Bronchial Spasm / Q000188:drug therapy; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D013997:Time Factors
D000336:Aerosols; D001507:Beclomethasone
Utilisation du dipropionate de béclométhasone en cures courtes dans le traitement des bronchopneumopathis obstructives spasmodiques.